Theo Riddick

Running Back

Age: 30
Free Agency: 2022 (UFA)
Accrued Seasons: 8
  • 2021 Salary Cap Charge: $900,000 (0.48% of cap)
  • 2021 Cash Payout: $1,175,000 (0.58% of spending)
  • 2021 Cash to Cap Ratio: 1.31
  • Contract Value: $1,175,000 ($1,175,000 APY)
  • Fully Guaranteed Money: $50,000
  • Contract Ranking: 63/194 at RB

Current Contract

(UFA, signed 2021)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusRoster BonusCap
Number
Cap %
Dead Money & Cap Savings
202130$1,075,000$50,000$50,000$900,0000.5%
Total$1,075,000$50,000$50,000$900,000

Contract Notes

Theo Riddick signed a three year, $11.5 million contract with the Lions. He received a $3.85 million signing bonus.

Cash Flows

- fully earned money
- unearned or partially earned money
$1.2M
2021
Cash Due$1,175,000
Running Cash$1,175,000
Career Earnings: $14,100,194
Career APY: $1,762,524
Potential Earnings: $15,020,265
Total Guarantees: $4,991,000
Largest Cash Payment: $4,650,000 (2016)
Largest Cap Number: $4,137,500 (2018)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
LionsDraftedRenegotiated20134$2,251,000$562,750$91,000$1,576,00070.0%$525,333
LionsExtensionTerminated20163$11,550,000$3,850,000$3,850,000$9,287,50080.4%$3,095,833
BroncosSFAExpired20191$2,500,000$2,500,000$1,000,000$2,500,000100.0%$2,500,000
RaidersSFATerminated20201$910,000$910,000$0$00.0%$0
RaidersPracticeRenegotiated20201$204,000$204,000$0$00.0%$0
RaidersPracticeElevated20201$204,000$204,000$0$00.0%$0
RaidersSFAExpired20201$910,000$910,000$0$481,76552.9%$481,765
RaidersUFAActive20211$1,175,000$1,175,000$50,000$50,0004.3%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Lions6$10,988,500$1,831,417$9,876,0000.0%$1,087,5000.0%
Broncos1$2,500,000$2,500,000$2,468,7500.0%$00.0%
Raiders1$611,694$611,694$397,0590.0%$79,9290.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2013Lions$405,000$22,750$0$0$0$0$427,7500.4%$496,000
2014Lions$495,000$22,750$0$0$0$0$517,7500.4%$495,000
2015Lions$585,000$22,750$0$0$0$0$607,7500.4%$585,000
2016Lions$800,000$985,250$0$0$0$0$1,785,2501.1%$4,650,000
2017Lions$1,075,000$962,500$175,000$100,000$125,000$0$2,400,0001.4%$1,475,000
2018Lions$2,700,000$962,500$0$100,000$125,000$0$4,137,5002.3%$3,162,500
2019Broncos$2,000,000$250,000$0$250,000$0$750,000$2,468,7501.3%$2,500,000
2020Raiders$910,000$0$0$0$0$0$397,0590.2%$481,765
2021Raiders$1,075,000$50,000$50,000$0$0$0$900,0000.5%$1,175,000
Total$10,045,000$3,278,500$225,000$450,000$250,000$750,000$13,641,809$15,020,265
Dead Money History
TeamYearCap ChargeCash Paid
Lions2019$1,087,500$125,000
Raiders2020$79,929$79,929
Total$1,167,429$204,929

Statistics

YearGames PlayedGames MissedSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
201314204.2%52.6%9252.814266.5000
2014142015.7%23.8%20512.60343169.3400
2015160043.5%23.2%431333.10806978.7311
2016106040.8%0.0%923573.91533717.0500
2017160045.2%0.0%802763.53514328.5211
2018142038.5%0.0%401714.30613846.3000
20204044.4%0.0%6142.305438.6000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$752,000$1,175,000
Injury Adjusted$752,000$1,175,000
test
OTC Valuation $2.6M $5.2M $7.8M $10.5M $13.1M APY $2.7M $5.3M $8.0M $10.7M $13.3M $6,038,000 $4,128,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.